FNDR website description (accessed 10/12/2022 and 10/8/2021): An inhalation peptide drug candidate (NF1001/PM181108) in partnership with National Centre of Oceanic and Antarctic Research (NCAOR) Goa, for Rx of MDR/XDR TB: We have a natural product derived peptide antibiotic with excellent in vitro and in vivo activity in mouse and guinea pig TB infection models. Peptide candidate kills TB through a novel mode of action by inhibiting ribosome associated GTPase activity blocking protein translation.
